(TheNewswire)
VANCOUVER, BC / May 31,2024 / TheNewswire / AREV Life Sciences Global Corp. (CSE: AREV)(OTC: AREVF) (“AREV” or “the Company” ) Arev Life Sciences Global Corp (CSE: AREV, US AREVF), aleading innovator in the life sciences, is pleased to announce itsstrong support for the recent passage of Bill C-368 in the CanadianParliament. This landmark legislation amends the Food and Drugs Act toensure that natural health products (NHPs) are not subject to the samestringent regulatory framework as pharmaceutical drugs, preservingtheir accessibility and affordability for Canadians.
Supporting Combination Therapy andHealth Maintenance
Bill C-368 marks a significant victory for the naturalhealth products industry and for consumers who rely on these productsfor their daily health and wellness needs. By distinguishing NHPs fromtherapeutic products, the legislation acknowledges the unique rolethat natural products play in supporting health and well-being.
"Natural products are a vital component ofcombination therapy," stated Michael Withrow, CEO of Arev LifeSciences Global Corp. "They offer synergistic benefits when usedalongside conventional treatments, enhancing the efficacy ofpharmaceuticals and supporting the maintenance of good health. Thisbill ensures that Canadians continue to have access to these essentialproducts without the undue burden of over-regulation."
Preserving Industry and ConsumerChoice
The natural health products industry is a significantcontributor to the Canadian economy, employing over 54,000 people andgenerating substantial economic activity. The passage of Bill C-368ensures the sustainability of this industry, protecting smallbusinesses and preserving consumer choice.
"We applaud the Canadian Parliament forrecognizing the importance of natural health products," addedWithrow. "The distinction made by Bill C-368 between NHPs andtherapeutic drugs is a crucial step in maintaining the accessibilityand affordability of these products. This is not just a win for theindustry but also for the millions of Canadians who use natural healthproducts daily to enhance their quality of life."
For further information,contact Mike Withrow, arevlifesciences@gmail.com 778-896-6536. Formore information visit www.arevlifesciences.com.
On behalf of the Board,
Michael C. Withrow
CEO &Director
About AREV Life Sciences GlobalCorp.
Arev Life Sciences Global Corp is a biotechnologycompany dedicated to the discovery and commercialization of innovativesolutions for health and wellness. The company's mission is to harnessthe power of natural compounds to develop effective, sustainablehealth products that complement conventional therapies and supportoverall health.
NEITHER THE CANADIAN SECURITIES EXCHANGENOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPTRESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THISRELEASE.
Neither the Canadian Securities Exchangenor its Regulation Services Provider (as that term is defined inpolicies of the CSE) accepts responsibility for the adequacy oraccuracy of this release. This news release may includeforward-looking statements that are subject to risks anduncertainties. All statements within, other than statements ofhistorical fact, are to be considered forward looking. Although theCompany believes the expectations expressed in such forward lookingstatements are based on reasonable assumptions, such statements arenot guarantees of future performance and actual results ordevelopments may differ materially from those in forward-lookingstatements. Factors that could cause actual results to differmaterially from those in forward-looking statements include marketprices, exploitation and exploration successes, and continuedavailability of capital and financing, and general economic, market orbusiness conditions. There can be no assurances that such statementswill prove accurate and, therefore, readers are advised to rely ontheir own evaluation of such uncertainties. We do not assume anyobligation to update any forward-looking statements except as requiredunder the applicable laws. This press release contains forward-lookingstatements. The use of any of the words "anticipate","continue", "estimate", "expect","may", "will", "project","should", "believe" and similar expressions areintended to identify forward-looking statements. Although theCompany believes that the expectations and assumptions on which theforward-looking statements are based are reasonable, undue relianceshould not be placed on the forward-looking statements because theCompany can give no assurance that they will prove to be correct.Since forward-looking statements address future events and conditions,by their very nature they involve inherent risks and uncertainties.These statements speak only as of the date of this press release.Actual results could differ materially from those currentlyanticipated due to a number of factors and risks various risk factorsdiscussed in the Company’ s Management ’sDiscussion and Analysis under the Company’s profile on www.sedarplus.ca.
Copyright (c) 2024 TheNewswire - All rights reserved.